$ERAS Cashflow Statement | Understand Stock

$ERAS

$15.22 +$0.23 (1.53%) Close

$ERAS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation expense
In-process research and development expenses
Issuance of common stock to Erasca Foundation
Accretion on marketable securities, net
Change in fair value of preferred stock purchase right liability
Gain on remeasurement of operating lease assets and liabilities
Impairment charge on operating lease assets and property and equipment
Impairment charge on investment in equity securities
Changes in operating assets and liabilities:
Prepaid expenses and other current and long-term assets
Accounts payable
Accrued expenses and other current liabilities
Accrued expenses and other current and long-term liabilities
Operating lease assets and liabilities, net

Net cash used in operating activities
Cash flows from investing activities:
Purchases of investments
Maturities of investments
Purchases of marketable securities
Maturities of marketable securities
In-process research and development
Payment made for investment in equity securities
Purchases of property and equipment
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Proceeds from the issuance of common stock in initial public offering, net of discounts and offering costs
Proceeds from the issuance of convertible preferred stock, net of issuance costs
Proceeds from issuance of common stock in private placement, net of fees and expenses
Proceeds from issuance of common stock
Underwritten Offering
ATM offering
Total proceeds from issuance of common stock

Proceeds from the exercise of stock options
Proceeds from issuance of common stock under the Employee Stock Purchase Plan
Proceeds from the disgorgement of stockholder's short-swing profits
Net cash provided by financing activities

Net increase (decrease) in cash, cash equivalents, and restricted cash
Cash, cash equivalents and restricted cash at beginning of the period
Cash, cash equivalents and restricted cash at end of the period
Supplemental disclosure of noncash investing and financing activities:
Issuance of common stock to Erasca Foundation
Issuance of common stock in connection with asset acquisition
Issuance of common stock in connection with license agreement
Amounts accrued for in-process research and development expenses
Amounts accrued for purchases of property and equipment
Amounts accrued for offering costs
Conversion of preferred stock to common stock upon initial public offering
Vesting of early exercised options
Operating lease assets obtained in exchange for lease obligation
Reduction in operating lease assets due to lease amendment
Tenant improvement allowance included in operating lease liabilities

Comments